The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia.
Thorsten
T
Zenz
Sonja
S
Häbe
Axel
A
Benner
Dirk
D
Kienle
Hartmut
H
Döhner
Stephan
S
Stilgenbauer
D002851:Chromatography, High Pressure Liquid; D015331:Cohort Studies; D005260:Female; D005838:Genotype; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D008297:Male; D009154:Mutation; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D016016:Proportional Hazards Models; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics* / Q000502:physiology; D017422:Sequence Analysis, DNA; D016896:Treatment Outcome
C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2